The use of instrumented gait analysis for individually tailored interdisciplinary interventions in children with cerebral palsy: a randomised controlled trial protocol

Rasmussen, HM, Pedersen, NW, Overgaard, S, Hansen, LK, Dunkhase-Heinl, U, Petkov, Y, Engell, V, Baker, RJ and Holsgaard-Larsen, A 2015, 'The use of instrumented gait analysis for individually tailored interdisciplinary interventions in children with cerebral palsy: a randomised controlled trial protocol' , BMC Pediatrics, 15 (1) .

Full text not available from this repository.

Abstract

Background Children with cerebral palsy (CP) often have an altered gait. Orthopaedic surgery, spasticity management, physical therapy and orthotics are used to improve the gait. Interventions are individually tailored and are planned on the basis of clinical examinations and standardised measurements to assess walking (‘care as usual’). However, these measurements do not describe features in the gait that reflect underlying neuro-musculoskeletal impairments. This can be done with 3-dimensional instrumented gait analysis (IGA). The aim of this study is to test the hypothesis that improvements in gait following individually tailored interventions when IGA is used are superior to those following ‘care as usual’. Methods/Design A prospective, single blind, randomised, parallel group study will be conducted. Children aged 5 to 8 years with spastic CP, classified at Gross Motor Function Classification System levels I or II, will be included. The interventions under investigation are: 1) individually tailored interdisciplinary interventions based on the use of IGA, and 2) ‘care as usual’. The primary outcome is gait measured by the Gait Deviation Index. Secondary outcome measures are: walking performance (1-min walk test) and patient-reported outcomes of functional mobility (Pediatric Evaluation of Disability Inventory), health-related quality of life (The Pediatric Quality of Life Inventory Cerebral Palsy Module) and overall health, pain and participation (The Pediatric Outcome Data Collection Instrument). The primary endpoint for assessing the outcome of the two interventions will be 52 weeks after start of intervention. A follow up will also be performed at 26 weeks; however, exclusively for the patient-reported outcomes. Discussion To our knowledge, this is the first randomised controlled trial comparing the effects of an individually tailored interdisciplinary intervention based on the use of IGA versus ‘care as usual’ in children with CP. Consequently, the study will provide novel evidence for the use of IGA.

Item Type: Article
Schools: Schools > School of Computing, Science and Engineering
Journal or Publication Title: BMC Pediatrics
Publisher: BioMed Central
ISSN: 1471-2431
Depositing User: WM Taylor
Date Deposited: 04 Nov 2016 13:53
Last Modified: 21 Apr 2017 10:12
URI: http://usir.salford.ac.uk/id/eprint/40599

Actions (login required)

Edit record (repository staff only) Edit record (repository staff only)